BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24153116)

  • 1. The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein.
    Zhao Y; Zhang G; Wei M; Lu X; Fu H; Feng F; Wang S; Lu W; Wu N; Lu Z; Yuan J
    Cancer Biol Ther; 2014 Jan; 15(1):108-18. PubMed ID: 24153116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.
    Bian Y; Wang L; Lu H; Yang G; Zhang Z; Fu H; Lu X; Wei M; Sun J; Zhao Q; Dong G; Lu Z
    Biochem Biophys Res Commun; 2012 May; 422(1):187-93. PubMed ID: 22569043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.
    Yu C; Wu G; Dang N; Zhang W; Zhang R; Yan W; Zhao Y; Gao L; Wang Y; Beckwith N; Yuan J; Yao L
    Cancer Biol Ther; 2011 Aug; 12(4):304-13. PubMed ID: 21623166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
    Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
    J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Methylation and Reduced Expression of the Quaking Gene in Colorectal Cancer.
    Iwata N; Ishikawa T; Okazaki S; Mogushi K; Baba H; Ishiguro M; Kobayashi H; Tanaka H; Kawano T; Sugihara K; Uetake H
    Anticancer Res; 2017 Feb; 37(2):489-498. PubMed ID: 28179294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer.
    Yang G; Fu H; Zhang J; Lu X; Yu F; Jin L; Bai L; Huang B; Shen L; Feng Y; Yao L; Lu Z
    Gastroenterology; 2010 Jan; 138(1):231-40.e1-5. PubMed ID: 19686745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking.
    He B; Gao SQ; Huang LD; Huang YH; Zhang QY; Zhou MT; Shi HQ; Song QT; Shan YF
    Mol Med Rep; 2015 Mar; 11(3):2355-9. PubMed ID: 25420938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth.
    Fort RS; Mathó C; Geraldo MV; Ottati MC; Yamashita AS; Saito KC; Leite KRM; Méndez M; Maedo N; Méndez L; Garat B; Kimura ET; Sotelo-Silveira JR; Duhagon MA
    BMC Cancer; 2018 Feb; 18(1):127. PubMed ID: 29394925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.
    Lu W; Feng F; Xu J; Lu X; Wang S; Wang L; Lu H; Wei M; Yang G; Wang L; Lu Z; Liu Y; Lei X
    Cancer Biol Ther; 2014 Sep; 15(9):1174-84. PubMed ID: 24918581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
    Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
    J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
    Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
    Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of activator protein-1 regulated by interferon expression in prostate cancer tissues and cells.
    Zhang S; Rong P; Chen Q; Wang W
    Life Sci; 2019 Sep; 232():116626. PubMed ID: 31276688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-binding protein QKI regulates contact inhibition via Yes-associate protein in ccRCC.
    Zhu Z; Wei D; Li X; Wang F; Yan F; Xing Z; Yan Z; Lu H; Zhai D; Ye Z; Zhang G; Meng P; Zheng Y; Yuan J; Lu Z; Yuan J
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):9-19. PubMed ID: 30566575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
    Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
    Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
    Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
    Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.
    Zhang RL; Yang JP; Peng LX; Zheng LS; Xie P; Wang MY; Cao Y; Zhang ZL; Zhou FJ; Qian CN; Bao YX
    Cell Cycle; 2016 Nov; 15(22):3094-3104. PubMed ID: 27767378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.